Bexorg

Bexorg

Private
New Haven, ConnecticutHealthcare & Life Scienceshttps://bexorg.com

Last Round

Series A

Oct 15, 2025

Total Funding Raised

$42.5M

Company Overview

Bexorg is a biotechnology company that has developed a whole-brain perfusion technology platform for central nervous system (CNS) drug discovery and development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Government Contracts

AI Layer

Application

Keywords

CNS drug discoverydrug discovery platformex vivo experimentationwhole-brain perfusionAI for drug discoverypostmortem brain researchpredictive preclinical modelstechbio platformhuman tissue modelsalternative to animal modelsbiomarker discoverypharmacokinetics servicesCNS databiotech equipmentdata licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bexorg Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Bexorg Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AOct 15, 2025
SeedJun 11, 2025

Bexorg Investors

Notable investors and investment history

InvestorRounds
Connecticut InnovationsSeries A
Engine VenturesSeries A
Starbloom CapitalSeries A, Seed
E1 VenturesSeries A
Engine VenturesSeries A
Amplify PartnersSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 10, 2026

    Training 'Virtual Proteome' AI models to unify multi-modal imaging and informatics data.

  • Mar 10, 2026

    Developing a 'High-Throughput Brain Slice Platform' from alpha to industrial scale.

Bexorg Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bexorg Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bexorg's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew Haven, Connecticut
Year Founded2021
Last FundingOct 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.